Insmed and Premacure announce European orphan designation for retinopathy drug
Premacure intends to initiate a Phase II multicenter trial for Iplex in the retinopathy of prematurity indication during the second quarter of 2009. With an orphan designation in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.